Literature DB >> 3418280

Are malignant melanoma time trends explained by changes in histopathological criteria for classifying pigmented skin lesions?

R Philipp1, A Hastings, J Briggs, J Sizer.   

Abstract

The incidence of malignant melanoma in developed countries has been rising rapidly in recent years. Its causes and the reasons for this trend are uncertain. Changes in histopathological criteria for classifying pigmented skin lesions could explain the rising incidence rates. With support from the International Agency for Research on Cancer, this hypothesis is explored but not substantiated for time trends in the South Western Region, United Kingdom.

Entities:  

Mesh:

Year:  1988        PMID: 3418280      PMCID: PMC1052674          DOI: 10.1136/jech.42.1.14

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  11 in total

1.  Incidence of malignant melanoma of the skin in Norway, 1955-1970. Variations in time and space and solar radiation.

Authors:  K Magnus
Journal:  Cancer       Date:  1973-11       Impact factor: 6.860

2.  A study of 650 observed malignant melanomas in the South-West region.

Authors:  D C Bodenham
Journal:  Ann R Coll Surg Engl       Date:  1968-10       Impact factor: 1.891

3.  The pathogenesis of cutaneous malignant melanoma.

Authors:  R M MacKie
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-26

4.  Incidence and reporting of cutaneous melanoma in Queensland.

Authors:  A Green
Journal:  Australas J Dermatol       Date:  1982-12       Impact factor: 2.875

5.  Malignant melanoma in Scotland 1979-1983.

Authors:  R M MacKie; J F Smyth; D S Soutar; K C Calman; A C Watson; J A Hunter; K M McLaren; J B MacGillivray; J L McPhie; R Rankin
Journal:  Lancet       Date:  1985-10-19       Impact factor: 79.321

6.  Trends in malignant melanoma of skin in New Zealand.

Authors:  K R Cooke; D C Skegg; J Fraser
Journal:  Int J Cancer       Date:  1983-06-15       Impact factor: 7.396

7.  Incidence of malignant melanoma of the skin in England and Wales and its relationship to sunshine.

Authors:  A J Swerdlow
Journal:  Br Med J       Date:  1979-11-24

8.  An approach to histopathological audit in Bristol.

Authors:  J H Smith; S Z Al-Sam; J C Briggs; J D Davies
Journal:  Bristol Med Chir J       Date:  1986-04

9.  Clinical diagnostic accuracy in the management of primary Stage I cutaneous malignant melanoma in a plastic surgery unit.

Authors:  R W Griffiths; J C Briggs; R W Hiles
Journal:  Bristol Med Chir J       Date:  1984-04

10.  Malignant melanoma incidence and association with arsenic.

Authors:  R Philipp; A O Hughes; M C Robertson; T F Mitchell
Journal:  Bristol Med Chir J       Date:  1983-10
View more
  4 in total

1.  A nationwide survey of observer variation in the diagnosis of thin cutaneous malignant melanoma including the MIN terminology. CRC Melanoma Pathology Panel.

Authors: 
Journal:  J Clin Pathol       Date:  1997-03       Impact factor: 3.411

Review 2.  Early detection and prevention of cutaneous malignant melanoma: emphasis on Swedish activities.

Authors:  U Ringborg; B Lagerlöf; M Broberg; E Månsson-Brahme; A Platz; M Thörn
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

Review 3.  Trends in cancer survival and mortality rates.

Authors:  J Pontén; H O Adami; P Sparén
Journal:  Med Oncol Tumor Pharmacother       Date:  1991

4.  Trends in tumour characteristics and survival of malignant melanoma 1960-84: a population-based study in Sweden.

Authors:  M Thörn; F Pontén; R Bergström; P Sparén; H O Adami
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.